NBY News and Press, NovaBay Pharmaceuticals Inc. From 06/10/19

Gainers: NBY   +20.3% . CASY   +9.4% . KEG   +3.5% . CHAP   +3.2% . CXW   +2.7% . More news on: NovaBay Pharmaceuticals, Inc., Casey's General Stores, Inc., Key Energy Services, Inc., Stocks on the move, , News on ETFs Read more ...

NovaBay Pharmaceuticals' (NYSEMKT: NBY ) Avenova Direct is now available at affordable pricing and without a prescription on Amazon.com through the Company’s new direct-to-consumer online channel. More news on: NovaBay Pharmaceuticals, Inc., Healthcare stocks news, Stock...

Original formulation of Avenova ® for the management of bacterial dry eye is now available at an affordable price without a prescription NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova ® for ...

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova ® for the domestic eye care market, announces that on May 16, 2019 it received notice (the “Notice”) from the NYSE American LLC that ...

NovaBay Pharmaceuticals, Inc (NBY) Q1 2019 Earnings Conference Call May 09, 2019 4:30 PM ET Company Participants Bruce Voss - Investor Relations, LHA Justin Hall - Interim President & Chief Executive Officer Jason Raleigh - Interim Chief Financial Officer Conference Call P...

NovaBay (NYSEMKT: NBY ): Q1 GAAP EPS of -$0.28 misses by $0.15 . Revenue of $1.5M (-49.2% Y/Y) misses by $0.59M . Shares +10.5% . Press Release More news on: NovaBay Pharmaceuticals, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, ,

Conference call begins today at 4:30 p.m. Eastern time NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova ® for the domestic eye care market, reports financial results for the three mon...

Management to discuss new partner pharmacy program and expanded access to in-office direct channel NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova ® for the domestic eye care market, an...

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova ® for the domestic eye care market, announces that it will hold a virtual Annual Meeting of Stockholders on Thursday, May 30, 2019 at 5:00 p.m. Pac...

Affirms long-term commitment to make Avenova convenient for both eye care specialists and patients NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company, announces a new pharmacy partnering program in a continued effort to ensure all patients in the...